Atomoxetine-Induced Vocal Tics in a Patient With Schizophrenia

Raveendranathan, Dhanya ; Rao, Mukund G ; Varambally, Shivarama ; Venkatasubramanian, Ganesan ; Gangadhar, Bangalore N (2012) Atomoxetine-Induced Vocal Tics in a Patient With Schizophrenia The Journal of Neuropsychiatry and Clinical Neurosciences, 24 (4). E45-E46. ISSN 0895-0172

Full text not available from this repository.

Official URL:

Related URL:


To the Editor: Atomoxetine is a potent inhibitor of the presynaptic norepinephrine transporter (NET) and has minimal affinity for other neurotransmitter transporters and neuronal receptors. As per currently available evidence, atomoxetine has demonstrated efficacy in improving attention-deficit hyperactivity disorder (ADHD) symptoms in children with comorbid tics and has also significantly improved comorbid tic symptoms.1 Hence, it has been considered as an appropriate choice in patients with ADHD and comorbid tics, or with a history of possible medication-induced tics. However, here have been a few reports of atomoxetine-induced tics2–5 when used in children with ADHD.

Item Type:Article
Source:Copyright of this article belongs to American Psychiatric Association.
ID Code:118801
Deposited On:30 May 2021 04:50
Last Modified:30 May 2021 04:50

Repository Staff Only: item control page